Optimal Medical Therapy for Chronic Coronary Syndrome: Realities and Prospects
Combination therapy is the standard of treatment for virtually all current non-communicable diseases, primarily chronic coronary heart disease, in modern terminology - "chronic coronary syndrome" (CSS), arterial hypertension, chronic heart failure, diabetes mellitus. The need for a combina...
Main Authors: | P. A. Lebedev, I. K. Petrukhina, A. A. Garanin, E. V. Paranina |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2021-07-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2515 |
Similar Items
-
The association of angiotensin receptor blocker-based combination therapy with persistence and adherence in newly treated, uncomplicated hypertensive patients
by: Ah YM, et al.
Published: (2019-01-01) -
The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population‐based cross‐sectional study
by: Xiaoyang Luo, et al.
Published: (2024-09-01) -
Facing the Challenge of Lowering Blood Pressure and Cholesterol in the Same Patient: Report of a Symposium at the European Society of Hypertension
by: Bryan Williams, et al.
Published: (2020-01-01) -
Expanding role for single‐pill combination drug therapy in the initial treatment of hypertension?
by: Yanglong Li, et al.
Published: (2021-11-01) -
Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020
by: Catherine G. Derington, et al.
Published: (2023-06-01)